Greetings（ご挨拶）

謹啓

時下益々ご清栄のことと存じます。平素よりご理解とご協力を賜り深謝いたします。

　さて、この度2025年1月24日に第15回国際協力遺伝病遺伝子治療フォーラムを開催します。コロナウイルス・パンデミックもひとまずは収まり、今回も対面中心の開催を予定しています。
　今回のメインテーマは「遺伝性疾患の根治を目指して」です。遺伝病に対する遺伝子治療は現在世界的に順調に承認が進み、脊髄性筋萎縮症に対する遺伝子治療製剤はすでに日本でも承認・販売されており、血友病、副腎白質ジストロフィ、異染性白質ジストロフィ等に対する遺伝子治療製剤が欧米で承認されています。一方で従来安全とされていたレンチウイルスベクター、AAVでも重大な合併症事例が報告されており、有効性に加えて安全性に関しても再び議論が必要な時期に来ていると言えます。
　本フォーラムでは遺伝性疾患に対する遺伝子細胞治療および関連領域の最新知見・開発情報を共有し、根治に向けた議論が出来ればと考えております。また今後臨床実装化が進む中で、認定遺伝カウンセラーや遺伝専門看護師などの医療スタッフ、および開発を検討する企業関係者とも多くの情報を共有し、有意義な議論が出来ればと考えております。

宜しくお願い申しあげます。

謹白　

Welcome Greetings

We hope that you are enjoying your time and doing well. I would also like to express my deepest gratitude for your continued support and cooperation.

We are pleased to announce that the 15th International Collaborative Forum of Human Gene Therapy for Genetic Disease will be held on January 24, 2025, at the auditorium of the Jikei university school of medicine. The COVID-19 pandemic has been temporarily under control, and we are planning to hold this year's forum mainly in person.

The main theme of this forum is “Toward the Cure of Hereditary Diseases”. Gene therapy for genetic diseases is currently being steadily approved worldwide. Gene therapy product for spinal muscular atrophy have already been approved and marketed in Japan, and those for Inherited Retinal Dystrophy, hemophilia, β-Thalassemia, sickle cell anemia, ADA deficiency, adrenoleukodystrophy, and metachromatic leukodystrophy have been approved in the United States and Europe. On the other hand, serious complications have been reported with lentiviral vectors and Adeno-associated viral vectors, which were previously considered safe, and it is time to discuss safety as well as efficacy again.

In this forum, we hope to share the latest knowledge and development information on gene and cell therapy for genetic diseases and related fields, and to discuss the possibility of cure. And in the current situation where gene therapy is becoming more practical than ever before, we also hope to share a lot of information and have meaningful discussions with medical staff such as certified genetic counselor or certified nurse specialist in genetics nursing, as well as with corporate staff who are considering the development of gene therapy.

Thank you in advance for your cooperation.

Hiroshi Kobayashi M.D.
The Jikei University School of Medicine

Registration Fee（参加費）

Regular
（一般）

￥5,000.-

Student
（学生）

Admission free (with verification card)
無料（要・学生証提示）

Company
（企業）

￥20,000.-

Reception
（懇親会）

￥5,000.-　24^th January (Doors open 6:30 pm)

※参加費は「不課税」です（免税事業者のため事業者登録番号無し）